Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis
Bilal Salman, Student at University of Balamand, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Inflammation, adding:
”Neutrophil extracellular traps (NETs) are increasingly recognized as important mediators linking innate immunity, inflammation, thrombosis, and cardiovascular remodeling.
These figures from our most recent publication highlight potential therapeutic targets involved in ROS generation (Apocynin, DPI, Colchicine, Thiocyanate, Selenocyanate), ROS clearance (GSH + NAC), NET formation (GSK), NET clearance (DNase I), as well as immunomodulatory therapies (Anakinra, IL-1 monoclonal antibody, and anti-IL6R therapy).
Targeting ROS may reduce the signals that initiate NETosis. Targeting PAD4 may prevent NET formation directly, while DNase I can help remove NETs after they have formed. Immunomodulators such as anakinra, IL-1β blockade, and anti-IL-6R therapy instead target the inflammatory environment surrounding NETosis.
The major challenge is finding the right balance between suppressing pathological NETosis and preserving the essential antimicrobial functions of neutrophils.
NETosis therefore represents a fascinating therapeutic intersection between oxidative stress, innate immunity, inflammation, thrombosis, and cardiovascular disease.”
Title: Role of neutrophil extracellular traps in myocardial infarction pathogenesis, diagnosis, and treatment
Authors: Lea Aridi, Bilal Salman, Layan Ghraizi, Daniel Mhanna, Rima Haidar, Bernard Harbieh, Ghassan Nabbout, Frederic Harb, Sami Azar, Hilda E. Ghadieh

Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders